Solventum Corp
Research Solventum Corp (SOLV) on Bullrun: market cap USD 14.85B, P/E 10.7. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSOLV
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 14.85B
- P/E10.7
- Financial periodQ2 2026
- RevenueUSD 2.21B
- Net incomeUSD 92.00M
- Free cash flowUSD 144.00M
- Gross margin58.2%
Valuation Snapshot
latest market cap is USD 14.85B; P/E is 10.7.
Peer valuation comparison
Latest P/E is 10.67x versus a Healthcare sector median of 24.61x (56.6% below).
Latest P/E is 10.67x versus a United States median of 23.85x (55.3% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 8.33B | USD 1.56B | -USD 10.00M | 53.5% | 8.88 | USD 878.00M | USD 5.04B | USD 5.05B |
| FY2024 | USD 8.25B | USD 479.00M | USD 805.00M | 55.6% | 2.76 | USD 762.00M | USD 8.01B | USD 2.96B |
| FY2023 | USD 8.20B | USD 1.35B | USD 1.63B | 57.3% | 7.79 | USD 194.00M | USD 0 | USD 11.67B |
| FY2022 | USD 8.13B | USD 1.34B | USD 1.43B | 57.7% | 7.78 | USD 61.00M | n/a | USD 11.74B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 14.85B | 10.7 | n/a | n/a |
| 2025 | 2025-12-31 | USD 13.75B | 8.9 | n/a | n/a |
| 2024 | 2024-12-31 | USD 11.41B | 23.9 | n/a | n/a |
About Solventum Corp
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Solventum Corp's market cap?
Solventum Corp's market capitalization is USD 14.85B.
What is Solventum Corp's P/E ratio?
Solventum Corp's price-to-earnings (P/E) ratio is 10.7.
What does Solventum Corp do?
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V.